Gevo, Inc.
GEVO Nasdaq· Industrial Organic Chemicals
Last close · Oct 23, 2026
$1.16
KIRA · Stoqly’s AI analyst, in plain words
- Gevo, Inc. had $161M of revenue in fiscal 2025, up 849.3% on the year before. Over five years, revenue changed +96.1% a year on average.
- Its operating margin was −12.6%, up 524.4 pts: of every 100 in sales, about −13 is left after running the business.
- Gevo, Inc. lost $33.8M in fiscal 2025.
- Free cash flow was −$43.5M in fiscal 2025, −27.1% of revenue.
- Gevo, Inc. owes $84.3M more than it holds in cash, about 16.5 years of operating profit.
Market cap
$275M
P/E
—
Revenue
$161M
Net income
−$33.8M
Free cash flow
−$43.5M
Operating margin
−12.6%
Gevo, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+849.3%
Yes. Sales grew 849.3% last year.
Does it make a profit?
−21.1%
No. It lost money last year.
Does profit turn into cash?
−27.1%
No. It spent more cash than it brought in.
Is debt under control?
16.5x
Heavy. Repaying its debt would take 16.5 years of operating profit.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Gevo, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 5, 2026
- Legal name
- Gevo, Inc.
- CIK
- 0001392380
Gevo, Inc. · GEVO
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $0.7M | $1.2M | $17.2M | $16.9M | $161M |
| Revenue growth | −87.2% | 65.3% | 1,363.8% | −1.7% | 849.3% |
| Gross margin | −1,611.0% | — | — | — | — |
| Operating margin | −8,476.5% | −8,739.2% | −475.8% | −536.9% | −12.6% |
| Net income | −$59.2M | −$98.0M | −$66.2M | −$78.6M | −$33.8M |
| Net margin | −8,326.7% | −8,341.0% | −385.0% | −464.9% | −21.1% |
| Diluted EPS | −$0.30 | −$0.44 | −$0.28 | −$0.34 | −$0.14 |
| Cash | |||||
| Cash from operations | −$48.3M | −$44.3M | −$53.7M | −$57.4M | −$13.4M |
| Capital expenditure | $56.8M | $84.1M | $54.5M | $51.1M | $30.1M |
| Free cash flow | −$105M | −$128M | −$108M | −$108M | −$43.5M |
| FCF margin | −14,773.7% | −10,926.6% | −628.9% | −641.3% | −27.1% |
| Share buybacks | — | — | — | $4.7M | — |
| Share count change | 244.2% | 13.1% | 7.7% | −2.9% | 1.0% |
| Debt and strength | |||||
| Cash and short-term investments | $316M | $405M | $298M | $189M | $81.2M |
| Debt incl. finance leases | $88.2M | $67.8M | $68.4M | $69.3M | $165M |
| Shareholders' equity | $547M | $605M | $557M | $489M | $466M |
| Net debt / EBITDA | — | — | — | — | 16.5x |
| Current ratio | 12.0x | 16.3x | 4.2x | 8.4x | 1.8x |
| Interest coverage | −240.1x | −88.0x | −37.9x | −23.4x | −1.2x |
| Returns and quality | |||||
| Return on capital | −16.0% | −30.2% | −19.8% | −19.5% | −2.9% |
| Return on equity | −17.1% | −17.0% | −11.4% | −15.0% | −7.1% |
| Return on tangible equity | −11.0% | −16.4% | −12.0% | −16.5% | −10.3% |
| Piotroski F-score | 2 | 4 | 3 | 4 | 3 |
| Altman Z'' | 5.7 | 6.3 | 4.8 | 1.9 | −1.4 |
Insiders bought, 12 months
$0.1M
2 insiders
Insiders sold, 12 months
$2.8M
10 insiders
Of sales under plans
80%
$2.3M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Gevo, Inc. · GEVO
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.16 a share, the company is worth $275M.
Source: SEC EDGAR XBRL filings (CIK 0001392380). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.